Skip to main content
. Author manuscript; available in PMC: 2024 Jan 1.
Published in final edited form as: Ann Neurol. 2022 Nov 22;93(1):184–195. doi: 10.1002/ana.26542

Table 2.

A. Logistic regression model predicting diagnosis of dementia. For each pathological predictor, omnibus significance (via Wald χ2) is followed by odds ratios and significance for each predictor level. B. Supplemental model analyzing NIA-AA pathological categories comprising ADNC score as predictors of dementia.

A.
Pathology Odds Ratio (95% CI) Wald χ2 Significance
Lewy Body (Braak) 0.002*
Braak 4a 1.68 (0.16 – 18.08) 0.670
Braak 5a 7.46 (0.80 – 69.49) 0.078
Braak 6a 35.18 (3.21 – 385.64) 0.004*
ADNC 0.818
Lowb 1.33 (0.46 – 3.89) 0.601
Intermediateb 2.34 (0.42 – 13.11) 0.335
Highb 0.999
CAA 0.427
Minimalb 0.35 (0.02 – 6.48) 0.478
Mildb 0.51 (0.15 – 1.72) 0.280
Moderateb 0.11 (0.01 – 1.10) 0.061
Severeb 0.47 (0.03 – 7.32) 0.590
Arteriolosclerosis 0.436
Mildb 2.67 (0.14 – 52.01) 0.518
Moderateb 1.83 (0.09 – 36.77) 0.694
Severeb 13.11 (0.30 – 575.3) 0.182
B.
Pathology Odds Ratio (95% CI) Wald χ2 Significance
β-amyloid 2.257 0.521
Score 1c 2.64 (0.731 – 9.51) 2.196 0.138
Score 2c 1.37 (0.33 – 5.67) 0.192 0.662
Score 3c 1.53 (0.13 – 17.44) 0.116 0.733
NFT 0.852 0.837
Score 1c 0.39 (0.045 – 3.34) 0.746 0.388
Score 2c 0.56 (0.043 – 7.36) 0.194 0.659
Score 3c 3.0 x 10−6 0.999
Neuritic plaques 1.711 0.634
Score 1c 6.80 (0.39 – 120.1) 1.711 0.191
Score 2c 4.0 x 10−6 0.998
Score 3c 1.65 x 10−10 0.999

ADNC = Alzheimer disease neuropathologic change, CAA = Cerebral amyloid angiopathy, NFT = neurofibrillary tangles

*

denotes significance at p = 0.05.

Odds ratio with 95% CI could not be calculated.

a

Contrast with Braak stage 3.

b

Contrast with “none”.

c

Contrast with score 0.